This multitarget regulatory pattern underscores the central role of epigenetic modifications in maintaining the dynamic equilibrium of PCD pathways
The incidence of breast cancer is increasing each year, and there will be more than 3 million new breast cancer cases annually by 2040 (Nagini, 2017), patients still face the risk of recurrence and mortality, with 685,000 deaths recorded in 2020 (Courtney et al., 2022)
Anisimov, V.N., et al., Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
Am J Pharmacogenomics 4(3):189-98, 2004
Therefore, in reference to the ILEP recommendations [2], the authors of these guidelines point to the need of possibly optimum non-pharmacological management (lifestyle modification), and in case of failure (unfortunately, this may apply to up to 80% of individuals) [152], after not more than 6 months, to consider initiation of pharmacological treatment, i.e
A study using 92% pure BPC-157 may show marginal effects while 98% purity at the same dose produces statistically significant mucosal healing purity directly determines reproducibility